Research Article
Sexual Effect of Platelet-to-Lymphocyte Ratio in Predicting Cardiovascular Mortality of Peritoneal Dialysis Patients
Table 3
Associations of PLR with all-cause and CVD mortality in univariate and multivariate Cox regression models
.
| Variable | All-cause mortality unadjusted model | Multivariate model | Cardiovascular mortality unadjusted model | Multivariate model | HR (95% CI) | value | HR (95% CI) | value | HR (95% CI) | value | HR (95% CI) | value |
| Age (y) | 1.063 (1.056-1.071) | <0.001 | 1.056 (1.047-1.065) | <0.001 | 1.065 (1.054-1.076) | <0.001 | 1.054 (1.041-1.068) | <0.001 | Gender (female, , %) | | | | | | | | | Female | 0.978 (0.804-1.191) | 0.826 | 1.001 (0.817-1.226) | 0.995 | 0.877 (0.661-1.166) | 0.367 | 0.863 (0.640-1.163) | 0.333 | Male | Ref. | | Ref. | | Ref. | | Ref. | | History of CVD (yes/no) | | | | | | | | | Yes | 2.771 (2.242-3.425) | <0.001 | 1.373 (1.089-1.731) | 0.007 | 3.341 (2.496-4.471) | <0.001 | 1.655 (1.200-2.282) | 0.002 | No | Ref. | | Ref. | | Ref. | | Ref. | | Diabetes (yes/no) | | | | | | | | | Yes | 3.299 (2.706-4.021) | <0.001 | 1.650 (1.327-2.051) | <0.001 | 3.911 (2.959-5.171) | <0.001 | 1.999 (1.460-2.737) | <0.001 | No | Ref. | | Ref. | | Ref. | | Ref. | | HGB (g/L) | 0.990 (0.985-0.994) | <0.001 | 0.990 (0.985-0.996) | <0.001 | 0.991 (0.984-0.997) | 0.006 | 0.990 (0.982-0.998) | 0.015 | ALB (g/L) | 0.913 (0.895-0.932) | <0.001 | 0.972 (0.950-0.996) | 0.020 | 0.927 (0.901-0.955) | <0.001 | 0.994 (0.960-1.029) | 0.730 | eGFR (mL/min/1.73 m2) | 1.022 (1.013-1.031) | <0.001 | 1.017 (1.003-1.032) | 0.020 | 1.018 (1.003-1.034) | 0.017 | 1.000 (0.963-1.039) | 0.999 | PLR | 1.001 (1.000-1.003) | 0.005 | 1.000 (0.999-1.001) | 0.594 | 1.002 (1.001-1.004) | 0.002 | 1.001 (0.999-1.002) | 0.250 | Platelet inhibitor (yes/no) | | | | | | | | | Yes | 1.811 (1.301-2.520) | <0.001 | 0.893 (0.628-1.270) | 0.529 | 2.077 (1.333-3.236) | 0.001 | 0.936 (0.583-1.503) | 0.784 | No | Ref. | | Ref. | | Ref. | | Ref. | | β-Blockers | | | | | | | | | (yes/no) | Yes | 0.683 (0.560-0.833) | <0.001 | 0.850 (0.692-1.044) | 0.121 | 0.714 (0.538-0.946) | 0.019 | 0.862 (0.644-1.153) | 0.316 | No | Ref. | | Ref. | | Ref. | | Ref. | |
|
|
All the models were adjusted for age, gender, history of CVD, diabetic status, hemoglobin, serum albumin, estimated glomerular filtration rate, platelet inhibitor, and β-blockers. Abbreviations: PLR: the platelet-to-lymphocyte ratio; CVD: cardiovascular disease; HGB: hemoglobin; ALB: serum albumin; PLR: the platelet-to-lymphocyte ratio; eGFR: estimated glomerular filtration rate. |